Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Concord Drugs Limited
Since 1995, Concord Drugs Limited has maintained a presence in the industry for 31 years. Its CIN is L24230TG1995PLC020093, with registration number 20093. It is officially registered under the category of company limited by shares. Authorized capital of the company is recorded at ₹15.50 crore. Paid-up capital currently stands at ₹13.18 crore.
Its principal business sector is manufacture of chemicals and chemical products. It is registered in Hyderabad. It is incorporated at Survey No.249, Brahmanapally Village Hayatnagar Mandal R.r.d Ist-501511, Na, Telangana, India, 000000. It is officially listed as an active business entity. The entity’s PAN (Permanent Account Number) stands as AAACC8171D. The firm is registered with LEI code 98450014CO7460A4A188. For inquiries or official matters, please email concorddrugs@gmail.com. At the helm are Shobha Gopal Jadhav (CFO) and Koni Reddy Seelam (CFO).
Company Overview
- CIN
- Date of Incorporation
- 24/04/1995
- Company Status
- Active
- RoC
- Hyderabad
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹15,50,00,000.00
- Paid up Capital
- ₹13,17,50,000.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- concorddrugs@gmail.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Andhra Pradesh | 37AAACC8171D1ZT | Inactive |
| Telangana | 36AAACC8171D1ZV | Active |
| Uttarakhand | 05AAACC8171D1Z0 | Inactive |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE858L01010 | CONCORD DRUGS LIMITED EQ | - | 12/10/2026 | CONCORD DRUGS/SH VTG | ESVUFN |
| IN8858L01019 | CONCORD DRUGS LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | CONCORD DRUGS/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹1,336.88L | ₹1,356.86L | ₹1,266.67L | ₹1,320.42L | ₹0.00L |
| Net Debt | ₹1,332.11L | ₹1,912.29L | ₹1,737.33L | ₹1,688.63L | ₹0.00L |
| Gross PPE | ₹1,336.88L | ₹1,356.86L | ₹1,266.67L | ₹1,320.42L | ₹0.00L |
| Inventory | ₹2,551.60L | ₹2,526.87L | ₹2,292.31L | ₹2,006.47L | ₹0.00L |
| Total Debt | ₹1,359.92L | ₹1,924.38L | ₹1,751.87L | ₹1,696.47L | ₹0.00L |
| Common Stock | ₹1,317.50L | ₹1,000.00L | ₹1,000.00L | ₹931.55L | ₹0.00L |
| Current Debt | ₹1,179.33L | ₹1,791.94L | ₹1,687.33L | ₹1,505.34L | ₹0.00L |
| Share Issued | ₹131.75L | ₹100.00L | ₹100.00L | ₹93.15L | ₹0.00L |
| Total Assets | ₹7,488.76L | ₹6,514.18L | ₹5,880.64L | ₹5,823.10L | ₹0.00L |
| Capital Stock | ₹1,317.50L | ₹1,000.00L | ₹1,000.00L | ₹931.55L | ₹0.00L |
| Long Term Debt | ₹180.59L | ₹132.44L | ₹64.54L | ₹191.13L | ₹0.00L |
| Current Assets | ₹5,331.16L | ₹4,076.21L | ₹3,751.77L | ₹4,345.64L | ₹0.00L |
| Working Capital | ₹3,224.39L | ₹1,458.19L | ₹1,651.31L | ₹2,184.16L | ₹0.00L |
| Invested Capital | ₹6,211.31L | ₹5,335.75L | ₹5,133.65L | ₹4,866.91L | ₹0.00L |
| Other Properties | ₹1,093.77L | ₹1,157.21L | ₹1,103.62L | ₹1,228.33L | ₹0.00L |
| Common Stock Equity | ₹4,851.39L | ₹3,411.37L | ₹3,381.78L | ₹3,170.44L | ₹0.00L |
| Net Tangible Assets | ₹4,851.39L | ₹3,411.37L | ₹3,381.78L | ₹3,170.44L | ₹0.00L |
| Tangible Book Value | ₹4,851.39L | ₹3,411.37L | ₹3,381.78L | ₹3,170.44L | ₹0.00L |
| Current Liabilities | ₹2,106.77L | ₹2,618.02L | ₹2,100.46L | ₹2,161.48L | ₹0.00L |
| Long Term Provisions | ₹271.88L | ₹271.88L | ₹252.88L | ₹246.38L | ₹0.00L |
| Stockholders Equity | ₹4,851.39L | ₹3,411.37L | ₹3,381.78L | ₹3,170.44L | ₹0.00L |
| Other Equity Interest | ₹3,533.89L | ₹2,411.36L | ₹2,381.78L | ₹56.48L | ₹0.00L |
| Total Capitalization | ₹5,031.98L | ₹3,543.81L | ₹3,446.32L | ₹3,361.57L | ₹0.00L |
| Investment Properties | ₹63.95L | ₹63.95L | ₹63.95L | ₹63.95L | ₹0.00L |
| Ordinary Shares Number | ₹131.75L | ₹100.00L | ₹100.00L | ₹93.15L | ₹0.00L |
| Other Non Current Assets | ₹670.64L | ₹0.00L | ₹0.00L | -₹0.01L | ₹10.00L |
| Total Non Current Assets | ₹2,157.61L | ₹2,437.97L | ₹2,128.87L | ₹1,477.45L | ₹0.00L |
| Cash And Cash Equivalents | ₹27.81L | ₹12.09L | ₹14.54L | ₹7.84L | ₹0.00L |
| Construction In Progress | ₹243.11L | ₹199.65L | ₹163.05L | ₹92.09L | ₹0.00L |
| Other Short Term Investments | ₹51.01L | ₹10.45L | ₹3.10L | ₹2.10L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹4,851.39L | ₹3,411.37L | ₹3,381.78L | ₹3,170.44L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹2,637.37L | ₹3,102.81L | ₹2,498.86L | ₹2,652.66L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹1,179.33L | ₹1,791.94L | ₹1,687.33L | ₹1,505.34L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹180.59L | ₹132.44L | ₹64.54L | ₹191.13L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹78.82L | ₹22.54L | ₹17.64L | ₹9.94L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹530.60L | ₹484.79L | ₹398.40L | ₹491.18L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Free Cash Flow | -₹793.30L | ₹138.92L | -₹22.57L | ₹80.65L |
| Changes In Cash | ₹15.72L | -₹2.45L | ₹6.71L | ₹2.15L |
| End Cash Position | ₹27.81L | ₹12.09L | ₹14.54L | ₹7.84L |
| Financing Cash Flow | ₹805.58L | -₹142.82L | ₹28.34L | ₹62.40L |
| Investing Cash Flow | -₹113.25L | -₹231.82L | -₹100.86L | -₹226.56L |
| Operating Cash Flow | -₹676.61L | ₹372.19L | ₹79.23L | ₹166.30L |
| Capital Expenditure | -₹116.69L | -₹233.27L | -₹101.79L | -₹85.66L |
| Beginning Cash Position | ₹12.09L | ₹14.54L | ₹7.84L | ₹5.69L |
| Issuance Of Capital Stock | ₹317.50L | ₹0.00L | ₹68.45L | ₹188.67L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹318.69L | ₹271.81L | ₹249.64L | ₹297.72L | ₹0.00L |
| EBITDA | ₹455.36L | ₹414.89L | ₹405.18L | ₹460.28L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹105.50L | ₹33.62L | ₹47.23L | ₹98.55L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹1,109.09L | ₹1,001.42L | ₹1,167.04L | ₹1,107.57L | ₹0.00L |
| Pretax Income | ₹147.32L | ₹69.14L | ₹62.89L | ₹124.89L | ₹0.00L |
| Tax Provision | ₹41.82L | ₹35.52L | ₹15.66L | ₹26.34L | ₹0.00L |
| Total Revenue | ₹7,873.68L | ₹4,524.46L | ₹4,492.45L | ₹5,208.06L | ₹0.00L |
| Cost Of Revenue | ₹6,764.59L | ₹3,523.04L | ₹3,325.41L | ₹4,100.49L | ₹0.00L |
| Total Expenses | ₹7,555.00L | ₹4,252.67L | ₹4,238.70L | ₹4,904.00L | ₹0.00L |
| Interest Expense | ₹171.37L | ₹202.67L | ₹186.75L | ₹172.83L | ₹0.00L |
| Operating Income | ₹318.68L | ₹271.79L | ₹253.75L | ₹304.06L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹455.36L | ₹414.89L | ₹405.18L | ₹460.28L | ₹0.00L |
| Normalized Income | ₹105.50L | ₹33.62L | ₹47.23L | ₹98.55L | ₹0.00L |
| Operating Expense | ₹790.41L | ₹729.63L | ₹913.29L | ₹803.51L | ₹0.00L |
| Operating Revenue | ₹7,873.68L | ₹4,524.46L | ₹4,492.45L | ₹5,208.06L | ₹0.00L |
| Net Interest Income | -₹171.37L | -₹202.67L | -₹190.86L | -₹179.47L | ₹0.00L |
| Total Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | -₹1.48L | ₹0.00L |
| Basic Average Shares | ₹111.05L | ₹98.88L | ₹100.00L | ₹93.15L | ₹0.00L |
| Diluted Average Shares | ₹111.05L | ₹98.88L | ₹100.00L | ₹93.15L | ₹0.00L |
| Other Operating Expenses | ₹160.13L | ₹124.54L | ₹117.94L | ₹109.72L | ₹0.00L |
| Reconciled Depreciation | ₹136.67L | ₹143.08L | ₹155.54L | ₹162.56L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹6,764.59L | ₹3,523.04L | ₹3,325.41L | ₹4,100.49L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹171.37L | ₹202.67L | ₹186.75L | ₹172.83L | ₹0.00L |
| Net Income Common Stockholders | ₹105.50L | ₹33.62L | ₹47.23L | ₹98.55L | ₹0.00L |
| Net Income Continuous Operations | ₹105.50L | ₹33.62L | ₹47.23L | ₹98.55L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹105.50L | ₹33.62L | ₹47.23L | ₹98.55L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹0.00L | ₹0.00L | -₹1.48L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹171.37L | -₹202.67L | -₹190.86L | -₹179.47L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹105.50L | ₹33.62L | ₹47.23L | ₹98.55L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹105.50L | ₹33.62L | ₹47.23L | ₹98.55L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹105.50L | ₹33.62L | ₹47.23L | ₹98.55L | ₹0.00L |
Company Performance (FY23–FY26)
₹78.7 Cr₹59.1 Cr₹39.4 Cr₹19.7 Cr₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 04/04/2003 | Nagi Reddy Seelam | 01764665 | Managing Director | View other directorships |
| 10/06/2011 | Koni Reddy Seelam | 02829319 | Whole-time director | View other directorships |
| 30/03/2015 | Shobha Gopal Jadhav | *****3654R | CFO | |
| 30/03/2019 | Ramchandra Reddy Kommula | 02285257 | Director | View other directorships |
| 13/02/2021 | Nagavenkatahareeshkumar Solleti | 09066790 | Director | View other directorships |
| 13/08/2021 | Seelam Manojkumarreddy | 06991382 | Whole-time director | View other directorships |
| 01/06/2022 | Sumeela Kasu | 09571540 | Director | View other directorships |
| 19/03/2024 | Namratha | *****5746C | Company Secretary | |
| 30/09/2025 | Satyam Reddy Gopidi | 11282375 | Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 9
- Nagi Reddy SeelamManaging Director
- Seelam ManojkumarreddyWhole-time director
- Koni Reddy SeelamWhole-time director
- Satyam Reddy GopidiDirector
- Sumeela KasuDirector
- Nagavenkatahareeshkumar SolletiDirector
- Ramchandra Reddy KommulaDirector
- NamrathaCompany Secretary
- Shobha Gopal JadhavCFO
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 06/12/2024 | Form MGT-7-06122024_signed | - |
| 11/11/2024 | Form AOC-4(XBRL)-09112024 | - |
Charges
| SRN | Date | Amount | Holder |
|---|---|---|---|
| AA2067506 | 11/03/2022 | ₹5,00,00,000.00 | Icici Bank Limited |
| AB0343271 | 17/12/2011 | ₹18,25,00,000.00 | State Bank Of India |
| B62827605 | 10/11/2005 | ₹1,40,00,000.00 | Punjab National Bank |
| R21816855 | 01/01/1998 | ₹50,00,000.00 | Small Industries Development Bank Of India |
| R21817135 | 17/10/1997 | ₹50,00,000.00 | Small Industries Development Bank Of India |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Survey No.249, Brahmanapally Village Hayatnagar Mandal R.r.d Ist-501511, Na, Telangana, India, 000000
Frequently Asked Questions
What is the incorporation date of Concord Drugs Limited?
The incorporation date of Concord Drugs Limited is 24/04/1995.
What is the authorized share capital and paid-up capital of Concord Drugs Limited?
The authorized share capital of Concord Drugs Limited is ₹15,50,00,000.00. The paid-up capital is ₹13,17,50,000.00.
Who are the current board members & directors of Concord Drugs Limited?
The current board member of Concord Drugs Limited are:
- Nagi Reddy Seelam
- Shobha Gopal Jadhav
- Koni Reddy Seelam
- Seelam Manojkumarreddy
- Nagavenkatahareeshkumar Solleti
- Sumeela Kasu
- Ramchandra Reddy Kommula
- Satyam Reddy Gopidi
- Namratha
What is the registered address of Concord Drugs Limited?
The registered address of Concord Drugs Limited is Survey No.249, Brahmanapally Village Hayatnagar Mandal R.r.d Ist-501511, Na, Telangana, India, 000000.
What is the Corporate Identification Number of Concord Drugs Limited?
The Corporate Identification Number of Concord Drugs Limited is L24230TG1995PLC020093.